Lead Sponsor

Biogen

Age

20 - 55 years

Sex

ALL

Healthy Volunteers

Yes

•Japanese subjects must have been born in Japan, and their biological parents and grandparents must all have been of Japanese origin.
•Subjects who have lived out of Japan for more than 5 years must not have significantly modified their diets since leaving Japan.
•Must be a nonsmoker or light smoker (\<10 cigarettes per day) and be willing to abstain from using tobacco and tobacco-containing products during the Inpatient Period and for at least 48 hours prior to Day -1, Day 14 (for Cohort 3), and all outpatient visits.
•Must have a body mass index of 18 to 32 kg/m2, inclusive.

•History of any clinically significant cardiac, endocrine, hematologic, hepatic, immunologic, metabolic, urologic, pulmonary, neurologic, dermatologic, psychiatric, renal, or other major disease, as determined by the Investigator.
•Serious infection (e.g., pneumonia, septicemia) as determined by the Investigator within the 3 months prior to Day -1.
•Fever or bacterial or viral infection (including upper respiratory tract infection) within 2 weeks prior to Day -1.
•History of severe allergic or anaphylactic reactions.

Related studies

NCT07663266 · Multiple Sclerosis, Spinal Cord Injury

NCT07189325 · Relapsing-Remitting Multiple Sclerosis (RRMS), Anti-CD20 Therapy

NCT06170970 · Multiple Sclerosis, Multiple Sclerosis Fatigue

NCT06782490 · Multiple Sclerosis Spasticity

NCT07299019 · Secondary Progressive Multiple Sclerosis

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants